Nausea after your first Wegovy injection is not a warning sign — it's your body responding to a medication that's actively changing how you process food. Most people experience some side effects in the first week, but knowing exactly what's coming, when it peaks, and when it fades makes all the difference between pushing through and giving up too early.
What Side Effects Are Normal in the First Week of Wegovy?
The most common Wegovy side effects in the first week are gastrointestinal: nausea, vomiting, diarrhoea, constipation, and stomach cramps. These aren't random reactions — they're a direct result of how semaglutide works. Wegovy slows gastric emptying, the rate at which food leaves your stomach, which is part of why it suppresses appetite. That same mechanism is why your digestive system needs time to adjust.
Clinical trial data from the STEP programme found that nausea affected up to 44% of people taking semaglutide, making it the most reported side effect. You're starting on the lowest dose, so first-week effects are typically milder than what you might experience as your dose increases.
Common first-week side effects include:
- Nausea (most common — usually mild at starter dose)
- Constipation or loose stools
- Stomach cramps or bloating
- Headache
- Fatigue or low energy
- Burping or acid reflux
- Dizziness, particularly after eating
It's also completely normal not to experience any side effects in week 1. A smooth first week doesn't mean Wegovy isn't working — it means your body is tolerating the medication well.
When Do Wegovy Side Effects Start?
Wegovy side effects typically begin within 24–72 hours of the first injection. Semaglutide reaches peak blood concentration around 24–36 hours after each dose, which is when most people notice symptoms most strongly. The first 3 days after injection are usually the most uncomfortable.
After that initial peak, symptoms often ease significantly before your next weekly dose. If you're keeping a symptom diary — which is worth doing, especially in the first month — you'll likely notice a pattern: rough days 1–3, improving days 4–7.
How Long Do Wegovy Side Effects Last?
For most people, first-week side effects last between 2 and 5 days after each injection. As your body adjusts to semaglutide, the severity and duration of side effects typically decreases with each subsequent dose.
Clinical trial data shows that nausea rates drop significantly after the first 4–8 weeks of treatment, even as doses increase. A 2022 review in the Journal of Pharmacy Technology confirmed that GLP-1 gastrointestinal side effects are most intense early in treatment and tend to resolve or become manageable within the first 4–12 weeks.
| Timeframe | What's happening | Side effect intensity |
|---|---|---|
| Days 1–3 | Peak semaglutide concentration after injection | Highest — nausea most likely here |
| Days 4–7 | Concentration begins to taper | Easing — most people feel better |
| Weeks 2–4 | Body adjusting | Often mild or absent by week 3–4 |
| Weeks 5–8 | Dose increase | Can temporarily return, then eases again |
| Week 12+ | Established on therapeutic dose | Most people tolerate well at this stage |
Mounjaro Side Effects in the First Week — How Do They Compare?
Mounjaro (tirzepatide) causes very similar first-week side effects to Wegovy, because both medications work on the GLP-1 receptor. Mounjaro also activates GIP receptors, making it a dual agonist, but the early side effect profile — nausea, vomiting, diarrhoea, constipation — is largely the same.
You might notice that Mounjaro side effects feel slightly different in character for some people. Because tirzepatide has a stronger effect on gastric motility and appetite suppression at equivalent stages of dose escalation, some users report more pronounced nausea in the early weeks, and headaches are also common with Mounjaro — particularly in the first few days after injection.
| Side effect | Wegovy (semaglutide) | Mounjaro (tirzepatide) |
|---|---|---|
| Nausea | Up to 44% | Up to 31–45% |
| Diarrhoea | Up to 30% | Up to 23% |
| Constipation | Up to 24% | Up to 19% |
| Vomiting | Up to 24% | Up to 18% |
| Injection site reaction | Occasional | Up to 7% |
How Long Do Mounjaro Side Effects Last?
Mounjaro side effects follow a similar pattern to Wegovy: most intense in the first 1–3 days after each injection, improving through days 4–7, and typically becoming less severe as treatment continues. The SURMOUNT-1 trial found that most gastrointestinal side effects peaked during dose escalation and decreased significantly once participants reached their maintenance dose.
Most people find that Mounjaro side effects become manageable within 8–12 weeks. If side effects are persistent or severe beyond that window, it's worth speaking to your prescriber — a slower titration schedule is an option that helps many people stay on treatment comfortably.
How to Manage Nausea in the First Week
The most effective way to reduce Wegovy or Mounjaro nausea is to change how and what you eat, not to stop the medication. Semaglutide and tirzepatide slow digestion, so large, fatty, or rich meals put too much demand on a system that's already working differently.
Three foods that reduce GLP-1 nausea:
- Plain crackers or dry toast — easily digestible, low-fat, helps settle the stomach
- Ginger tea or ginger chews — research supports ginger's anti-nausea effects; a natural first option
- Cold or room-temperature foods — hot food has stronger aromas that can trigger nausea; cold options are easier to tolerate
Practical adjustments that help:
- Eat smaller meals more frequently rather than two or three large ones
- Avoid lying down immediately after eating
- Stay well hydrated — dehydration makes nausea significantly worse
- Time your injection for the evening if daytime nausea is problematic
- Avoid alcohol and high-fat, high-sugar foods in the first 72 hours after injection
When eating feels difficult in the first few days, structured options like ready-to-drink nutritional meals or protein-based meal replacements can help you maintain adequate nutrition without overwhelming a sensitive stomach. Small portions of something manageable are always better than skipping meals entirely — which can worsen nausea and fatigue.
One Meal Shake
Chocolate
- ✔ 12 bottles
- ✔ Only 218 kcal per bottle
- ✔ 21g protein per bottle
- ✔ Lactose-free and no added sugar
GLP-1 Long-Term Side Effects: What to Know Beyond Week 1
GLP-1 medications like Wegovy and Mounjaro are designed for long-term use, so it's worth understanding what the research says about effects beyond the first few months. The good news: for most people, the most uncomfortable side effects ease considerably after the first 8–12 weeks.
Longer-term side effects to be aware of include:
Rapid weight loss on GLP-1 medications can include loss of lean muscle mass, not just fat. Research published in Nature Medicine (2023) highlighted this as a meaningful consideration. Maintaining adequate protein intake (typically 1.2–1.6g per kg of body weight) and incorporating resistance exercise helps preserve muscle during treatment.
Eating significantly less means taking in fewer micronutrients. People on long-term GLP-1 therapy are at higher risk of deficiencies in vitamin B12, vitamin D, iron, and calcium. A daily multivitamin and regular blood tests are typically recommended by prescribers for long-term users.
Rapid weight loss of any kind — not specific to GLP-1 medications — increases gallstone risk. This is a known long-term consideration. Symptoms to watch for include upper-right abdominal pain, particularly after eating. Report these to your prescriber promptly.
Because GLP-1 medications slow gastric emptying as part of their mechanism, some long-term users — particularly those with pre-existing digestive conditions — can experience prolonged gastroparesis. This is relatively uncommon but worth discussing with your prescriber if you have a history of digestive issues.
For the majority of people using Wegovy or Mounjaro as prescribed, long-term side effects are manageable and outweighed by the metabolic and cardiovascular benefits of sustained weight loss. Regular check-ins with your clinical team are the most reliable safeguard.
Mounjaro Long-Term Side Effects
Mounjaro's long-term side effect profile is largely similar to Wegovy's, given the shared GLP-1 mechanism. The SURMOUNT-4 trial, which followed participants for 88 weeks, found that gastrointestinal side effects remained the most common class of adverse events but were predominantly mild-to-moderate in severity.
Tirzepatide-specific long-term considerations include a slightly higher rate of injection site reactions compared to semaglutide, and the same cautions around muscle preservation, micronutrient intake, and gallstone risk apply. Thyroid C-cell tumours were observed in animal studies at high doses, and both Wegovy and Mounjaro carry a precautionary label advising against use in people with a personal or family history of medullary thyroid cancer — though this risk has not been confirmed in human studies.
